| Title |
Breast self-exam and patient interval associate with advanced breast cancer and treatment delay in Mexican women
|
|---|---|
| Published in |
Clinical and Translational Oncology, April 2017
|
| DOI | 10.1007/s12094-017-1666-6 |
| Pubmed ID | |
| Authors |
E. Leon-Rodriguez, C. Molina-Calzada, M. M. Rivera-Franco, A. Campos-Castro |
| Abstract |
The objective of this study was to compare treatment intervals in breast cancer patients according to the detection method (breast self-exam vs screening). We conducted a retrospective analysis including 291 breast cancer patients at a Mexican tertiary referral hospital. Breast cancer detection method was mostly breast self-exam (60%). The median patient interval was 60.5 days, and was associated with marital status and socioeconomic level. Differences between the two groups were statistically significant for global interval, p = 0.002; however, health system interval was not statistically different. In our country, breast cancer screening is opportunistic, with several weaknesses within its management and quality systems. Our study showed that even in specialized health care centers, breast cancer is detected by self-exam in up to 2/3 of patients, which can explain the advanced stages at diagnosis in our country. In developing countries, the immediate health care access for breast cancer patients should be prioritized as an initial step to reduce the global treatment initiation interval in order to reduce mortality. |
X Demographics
The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Mexico | 1 | 50% |
| Unknown | 1 | 50% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 2 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 65 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 65 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 7 | 11% |
| Student > Master | 6 | 9% |
| Lecturer | 6 | 9% |
| Researcher | 4 | 6% |
| Student > Postgraduate | 4 | 6% |
| Other | 10 | 15% |
| Unknown | 28 | 43% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 11 | 17% |
| Nursing and Health Professions | 10 | 15% |
| Social Sciences | 3 | 5% |
| Pharmacology, Toxicology and Pharmaceutical Science | 2 | 3% |
| Biochemistry, Genetics and Molecular Biology | 2 | 3% |
| Other | 5 | 8% |
| Unknown | 32 | 49% |
Attention Score in Context
This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 28 April 2017.
All research outputs
#18,349,015
of 23,577,654 outputs
Outputs from Clinical and Translational Oncology
#803
of 1,365 outputs
Outputs of similar age
#222,207
of 310,949 outputs
Outputs of similar age from Clinical and Translational Oncology
#12
of 23 outputs
Altmetric has tracked 23,577,654 research outputs across all sources so far. This one is in the 19th percentile – i.e., 19% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,365 research outputs from this source. They receive a mean Attention Score of 3.8. This one is in the 35th percentile – i.e., 35% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 310,949 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 23rd percentile – i.e., 23% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 23 others from the same source and published within six weeks on either side of this one. This one is in the 43rd percentile – i.e., 43% of its contemporaries scored the same or lower than it.